Michael E Lewis's Net Worth
$702 Thousand
Who is Michael E Lewis?
Michael E Lewis does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include POLYMEDIX, INC, Cara Therapeutics, Inc., and AEOLUS PHARMACEUTICALS, INC..
SEC CIK
Michael E Lewis's CIK is 0001297065
Past Insider Trading and Trends
2010 was Michael E Lewis's most active year for acquiring shares with 5 total transactions. Michael E Lewis's most active month to acquire stocks was the month of June. 2015 was Michael E Lewis's most active year for disposing of shares, totalling 6 transactions. Michael E Lewis's most active month to dispose stocks was the month of January. 2007 saw Michael E Lewis paying a total of $0.00 for 180,000 shares, this is the most they've acquired in one year. In 2015 Michael E Lewis cashed out on 43,572 shares for a total of $453,221.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
POLYMEDIX, INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.5366
Chief Scientific Advisor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| -2.25% | -7.26K |
$10.93 | -$79,373.66 | 314.99K |
Scheduled
|
Jan 26
| ||
Form 4
| -2.20% | -7.26K |
$11.66 | -$84,674.92 | 322.25K |
Scheduled
|
Jul 1
| ||
Form 4
| -2.16% | -7.26K |
$9.50 | -$68,989.00 | 329.51K |
Scheduled
|
Jun 1
| ||
Form 4
| -2.11% | -7.26K |
$10.64 | -$77,267.68 | 336.77K |
Scheduled
|
May 1
| ||
Form 4
| -2.07% | -7.26K |
$9.90 | -$71,893.80 | 344.04K |
Scheduled
|
Apr 1
| ||
Form 4
| -2.03% | -7.26K |
$10.11 | -$73,418.82 | 351.3K |
Scheduled
|
Mar 2
| ||
Form 4
| -1.99% | -7.26K |
$10.60 | -$76,977.20 | 358.56K |
Scheduled
|
Feb 2
| ||
Form 4
| +13.52% | 43.57K |
—
|
—
| 365.82K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AEOLUS PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13 - Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28 - Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||